Related references
Note: Only part of the references are listed.Minimal Clinically Important Difference in the Fibromyalgia Impact Questionnaire
Robert M. Bennett et al.
JOURNAL OF RHEUMATOLOGY (2009)
Mechanisms of analgesia by gabapentin and pregabalin - Calcium channel alpha(2)-delta [Ca-v alpha(2)-delta] ligands
Charles P. Taylor
PAIN (2009)
A systematic review on the effectiveness of treatment with antidepressants in fibromyalgia syndrome
Nurcan Ueceyler et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials
Asquad Sultan et al.
BMC NEUROLOGY (2008)
Enriched enrolment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review
Sebastian Straube et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Fibromyalgia syndrome: Approach to management
I. Jon Russell
CNS SPECTRUMS (2008)
Fibromyalgia syndrome: Presentation, diagnosis, differential diagnosis, and vulnerability
I. Jon Russell et al.
CNS SPECTRUMS (2008)
A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia
Lesley M. Arnold et al.
JOURNAL OF PAIN (2008)
Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations
Robert H. Dworkin et al.
JOURNAL OF PAIN (2008)
Responder analysis and correlation of outcome measures: pooled results from two identical studies comparing etoricoxib, celecoxib, and placebo in osteoarthritis
C. O. Bingham et al.
OSTEOARTHRITIS AND CARTILAGE (2008)
Enriched enrolment with randomised withdrawal (EERW): Time for a new look at clinical trial design in chronic pain
Henry J. McQuay et al.
PAIN (2008)
Response to: Long-term trials of pregabalin and duloxetine for fibromyalgia symptoms: How study designs can affect placebo factors
R. A. Moore et al.
PAIN (2008)
Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): A 6-month, double-blind, placebo-controlled trial with pregabalin
Leslie J. Crofford et al.
PAIN (2008)
Amitriptyline in the treatment of fibromyalgia: a systematic review of its efficacy
B. Nishishinya et al.
RHEUMATOLOGY (2008)
Numbers needed to treat calculated from responder rates give a better indication of efficacy in osteoarthritis trials than mean pain scores
R. Andrew Moore et al.
ARTHRITIS RESEARCH & THERAPY (2008)
EULAR evidence-based recommendations for the management of fibromyalgia syndrome
S. F. Carville et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Pregabalin for the treatment of fibromyalgia syndrome - Results of a randomized, double-blind, placebo-controlled trial
LJ Crofford et al.
ARTHRITIS AND RHEUMATISM (2005)
Tolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis: systematic review and meta-analysis of information from company clinical trial reports
RA Moore et al.
ARTHRITIS RESEARCH & THERAPY (2005)
Treatment of fibromyalgia with cyclobenzaprine: A meta-analysis
JK Tofferi et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2004)
Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures
JA French et al.
NEUROLOGY (2003)
Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: A double-blind, randomized, placlebo-controlled study
RA Bennett et al.
AMERICAN JOURNAL OF MEDICINE (2003)
Publication and related bias in meta-analysis: Power of statistical tests and prevalence in the literature
JAC Sterne et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2000)
Misleading funnel plot for detection of bias in meta-analysis
JL Tang et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2000)
Teasing apart quality and validity in systematic reviews: an example from acupuncture trials in chronic neck and back pain
LA Smith et al.
PAIN (2000)
An evaluation of homogeneity tests in meta-analyses in pain using simulations of individual patient data
DJ Gavaghan et al.
PAIN (2000)
Share Paper
